GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Cefazolin

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

The source summary says "Maximum interval: q8h" whereas its package-insert paragraph specifies at least 8-hour intervals. This wording conflict is preserved for review.

Check source scope before reading a dose

Stanford adult Cefazolin

Product / population
Adult institutional dosing; not a manufacturer-label replacement.
Renal method
Not specified
Source revision
Antibiotic Subcommittee approved August 2026
Retrieved
2026-09-05
Local review status
Source-read local summary; source-specific recommendations are not automatically interchangeable.
Professional

Stanford adult Cefazolin

Open original reference

Stanford Antimicrobial Safety and Sustainability Program · Adult institutional dosing; not a manufacturer-label replacement.

Renal method: Not specified in this summary.
Source date: Antibiotic Subcommittee approved August 2026
Retrieved: 2026-09-05

Source-read local summary; source-specific recommendations are not automatically interchangeable.

Source-specific regimen

Limits that apply to these rows

Retained Stanford protocol. Do not mix with another institution's dialysis schedule.

Mild adult infection - IV
CrCl, mL/minSource-specific dose / instruction
>301 g every 8 hours
10-301 g every 12 hours
<101 g every 24 hours
Moderate/severe adult infection - IV
CrCl, mL/minSource-specific dose / instruction
>302 g every 8 hours
10-302 g every 12 hours
<102 g every 24 hours
Dialysis guidance - separate source-specific schedules
Stanford cefazolin dialysis
Dialysis setting / indicationSource-specific schedule
HD1 g daily, after dialysis on treatment days
CRRT2 g every 12 hours
Read the retained text before reformatting

Adult IV, CrCl >30 / 10-30 / <10 mL/min: mild infections 1 g every 8 / 12 / 24 hours; moderate/severe 2 g at those intervals. HD: 1 g daily, after dialysis on treatment days. CRRT: 2 g every 12 hours.

cefazolin:stanford-cefazolin-1 · Source locator: PDF page 2, Cefazolin row

Source identity and provenance
Source
https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-ABX-Dosing-Guide.pdf
Retrieved
2026-09-05
Source date/version
Antibiotic Subcommittee approved August 2026
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
046be365c61523c91e46daa4da8acf0d69c142f14720983f7f5537db184b0722

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=cefazolin&s1=stanford-cefazolin&h1=4bbe959451a49a42ccdb9910d19637c4973b6952c8b21c2281dcd4e8bb15c705